AMX0035
AMX-8000
Phase 2 small_molecule completed
Quick answer
AMX0035 for Alzheimer Disease is a Phase 2 program (small_molecule) at Amylyx Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amylyx Pharmaceuticals
- Indication
- Alzheimer Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed